Medicskin Holdings Limited (HKG:8307)
Hong Kong · Delayed Price · Currency is HKD 0.1180
+0.0050 (4.42%)
Jul 10, 2026, 6:15 PM HKT
Medicskin Holdings Ratios and Metrics
Market cap in millions HKD. Fiscal year is April - March.
Millions HKD. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 49 | 60 | 73 | 58 | 101 | 86 | |
Market Cap Growth | -42.25% | -18.92% | 27.59% | -43.14% | 16.97% | 6.34% |
Enterprise Value | 50 | 67 | 75 | 59 | 101 | 73 |
Last Close Price | 0.12 | 0.15 | 0.18 | 0.14 | 0.26 | 0.22 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 52.14 | 63.58 | - | - | - | 22.05 |
PS Ratio | 1.01 | 1.23 | 1.60 | 1.15 | 2.20 | 1.76 |
PB Ratio | 9.34 | 11.39 | 17.50 | 7.59 | 9.55 | 6.10 |
P/TBV Ratio | 9.34 | 11.39 | 17.50 | 5.25 | 7.27 | 4.96 |
P/FCF Ratio | 11.50 | 14.02 | 8.86 | 6.31 | 106.94 | 44.88 |
P/OCF Ratio | 8.85 | 10.80 | 8.04 | 5.47 | 31.17 | 22.22 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 1.03 | 1.39 | 1.63 | 1.19 | 2.19 | 1.49 |
EV/EBITDA Ratio | 6.34 | 26.77 | - | - | - | 12.53 |
EV/EBIT Ratio | 75.21 | 101.38 | - | - | - | 19.92 |
EV/FCF Ratio | 11.69 | 15.76 | 9.04 | 6.50 | 106.73 | 38.01 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 3.36 | 3.36 | 5.43 | 0.76 | 1.13 | 1.32 |
Debt / EBITDA Ratio | 2.25 | 2.25 | 4.26 | 0.88 | 1.86 | 1.39 |
Debt / FCF Ratio | 4.14 | 4.14 | 2.75 | 0.63 | 12.61 | 9.69 |
Net Debt / Equity Ratio | 0.16 | 0.16 | 1.30 | -0.15 | 0.52 | 0.23 |
Net Debt / EBITDA Ratio | 0.34 | 0.34 | -2.95 | 1.54 | -7.80 | 0.55 |
Net Debt / FCF Ratio | 0.20 | 0.20 | 0.66 | -0.13 | 5.87 | 1.66 |
Asset Turnover | 0.89 | 0.89 | 0.94 | 1.15 | 0.89 | 0.85 |
Inventory Turnover | 8.79 | 8.79 | 8.16 | 7.51 | 8.51 | 10.01 |
Quick Ratio | 0.46 | 0.46 | 0.45 | 0.25 | 0.25 | 0.53 |
Current Ratio | 0.86 | 0.86 | 0.86 | 0.93 | 0.91 | 1.01 |
Return on Equity (ROE) | 19.87% | 19.87% | -57.44% | -34.13% | -28.98% | 24.26% |
Return on Assets (ROA) | 0.76% | 0.76% | -4.76% | -4.15% | -3.55% | 3.98% |
Return on Invested Capital (ROIC) | 10.88% | 8.40% | -46.21% | -25.44% | -17.47% | 51.23% |
Return on Capital Employed (ROCE) | 6.50% | 6.50% | -26.30% | -34.50% | -17.00% | 13.70% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 1.92% | 1.57% | -4.60% | -5.30% | -3.50% | 4.54% |
FCF Yield | 8.70% | 7.13% | 11.29% | 15.85% | 0.94% | 2.23% |
Buyback Yield / Dilution | - | - | - | - | - | 5.81% |
Total Shareholder Return | - | - | - | - | - | 5.81% |